Free Trial

Landore Resources (LND) Competitors

Landore Resources logo
GBX 3.16 -0.05 (-1.41%)
As of 11:25 AM Eastern

LND vs. AVO, FDP, TED, ZNWD, GSP, TUN, 1SN, MET1, POW, and ARCM

Should you be buying Landore Resources stock or one of its competitors? The main competitors of Landore Resources include Advanced Oncotherapy (AVO), FD Technologies (FDP), Ted Baker (TED), Zinnwald Lithium (ZNWD), Gensource Potash (GSP), Tungsten West (TUN), First Tin (1SN), Metals One (MET1), Power Metal Resources (POW), and Arc Minerals (ARCM).

Landore Resources vs. Its Competitors

Landore Resources (LON:LND) and Advanced Oncotherapy (LON:AVO) are both small-cap agriculture companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

3.2% of Landore Resources shares are held by institutional investors. Comparatively, 17.8% of Advanced Oncotherapy shares are held by institutional investors. 39.6% of Landore Resources shares are held by company insiders. Comparatively, 47.5% of Advanced Oncotherapy shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Landore Resources is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Landore ResourcesN/AN/A-£3.77M-£1.16-2.72
Advanced OncotherapyN/AN/A-£32.60M-£0.07N/A

Advanced Oncotherapy's return on equity of -67.34% beat Landore Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Landore ResourcesN/A -217.63% -106.31%
Advanced Oncotherapy N/A -67.34%-11.73%

In the previous week, Landore Resources' average media sentiment score of 0.00 equaled Advanced Oncotherapy'saverage media sentiment score.

Company Overall Sentiment
Landore Resources Neutral
Advanced Oncotherapy Neutral

Landore Resources has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500. Comparatively, Advanced Oncotherapy has a beta of 0.06, indicating that its share price is 94% less volatile than the S&P 500.

Summary

Advanced Oncotherapy beats Landore Resources on 6 of the 8 factors compared between the two stocks.

Get Landore Resources News Delivered to You Automatically

Sign up to receive the latest news and ratings for LND and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LND vs. The Competition

MetricLandore ResourcesOther Industrial Metals & Mining IndustryMaterials SectorLON Exchange
Market Cap£10.05M£1.10B£3.45B£3.18B
Dividend Yield6.74%6.19%5.13%5.04%
P/E Ratio-2.72137.45110.59166.92
Price / SalesN/A24,718.8533,652,867,097,056,100.00448,413.15
Price / Cash21.0024.7024.1727.93
Price / Book3.187.776.186.35
Net Income-£3.77M£71.98M£150.51M£5.89B
7 Day Performance30.43%3.81%3.44%0.76%
1 Month Performance3.44%8.61%5.89%49.50%
1 Year Performance-12.36%57.37%38.63%141.61%

Landore Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LND
Landore Resources
N/AGBX 3.16
-1.4%
N/A-13.6%£10.05MN/A-2.726
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
FDP
FD Technologies
N/AGBX 2,450
flat
N/A+57.9%£544.43M£196.89M-16.9740,100
TED
Ted Baker
N/AN/AN/AN/A£202.71M£428.24M-5.69740
ZNWD
Zinnwald Lithium
N/AGBX 4.90
+2.1%
N/A-34.1%£27.82MN/A-10,969.3323
GSP
Gensource Potash
N/AN/AN/AN/A£23.61MN/A-525.00N/A
TUN
Tungsten West
N/AGBX 9.50
+11.8%
N/A+168.6%£19.79M£804.19K-2.0215News Coverage
Gap Up
1SN
First Tin
N/AGBX 6.03
-0.4%
N/A-16.2%£19.19MN/A-602.5027
MET1
Metals One
N/AGBX 5.35
+4.1%
N/A+485.0%£16.49MN/A-41.033Positive News
Gap Up
High Trading Volume
POW
Power Metal Resources
N/AGBX 14.25
flat
N/A+6.7%£16.47M£83.93K0.0020
ARCM
Arc Minerals
N/AGBX 1.05
+10.5%
N/A-50.0%£15.50MN/A1.6835Gap Down
High Trading Volume

Related Companies and Tools


This page (LON:LND) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners